Joseli Lannes-Vieira Selected Research

Joseli Lannes-Vieira Research Topics

Disease

32	Infections 04/2023 - 06/2004
23	Chagas Disease (American Trypanosomiasis) 05/2024 - 02/2003
16	Cardiomyopathies (Cardiomyopathy) 04/2023 - 06/2008
14	Heart Diseases (Heart Disease) 01/2022 - 01/2014
9	Inflammation (Inflammations) 11/2023 - 04/2003
8	Myocarditis (Carditis) 10/2016 - 04/2003
7	Fibrosis (Cirrhosis) 11/2023 - 12/2010
5	Parasitemia 05/2024 - 05/2007
5	Persistent Infection 01/2022 - 02/2010
5	Heart Injuries 01/2020 - 01/2012
3	Necrosis 01/2023 - 06/2014
3	Neuroinflammatory Diseases 01/2023 - 01/2021
3	Memory Disorders (Memory Loss) 01/2023 - 01/2021
3	Toxoplasmosis 01/2022 - 03/2003
3	Meningoencephalitis 10/2012 - 09/2003
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 12/2017
2	Cysts 01/2022 - 01/2021
2	Virus Diseases (Viral Diseases) 01/2021 - 01/2019
2	Sinus Arrhythmia 01/2019 - 10/2016
2	Shock 05/2007 - 02/2003
1	Atrophy 01/2023
1	Communicable Diseases (Infectious Diseases) 11/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Chagas Cardiomyopathy 01/2021
1	Bradycardia 01/2020
1	Weight Loss (Weight Reduction) 12/2015
1	Hypertrophy 03/2015

Drug/Important Bio-Agent (IBA)

11	benzonidazole (benznidazole)IBA 05/2024 - 06/2008
10	CytokinesIBA 01/2023 - 02/2003
6	Interferon-gamma (Interferon, gamma)IBA 05/2018 - 04/2003
5	Chemokine ReceptorsIBA 04/2021 - 04/2003
5	VaccinesIBA 01/2021 - 02/2010
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 06/2008
4	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2015
4	Pentoxifylline (Trental)FDA LinkGeneric 01/2023 - 03/2015
3	Proteins (Proteins, Gene)FDA Link 05/2023 - 02/2010
3	Thomsen-Friedenreich antibodiesIBA 11/2022 - 09/2004
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2014
3	CC ChemokinesIBA 01/2020 - 09/2004
3	Met- RANTESIBA 01/2020 - 09/2004
3	Messenger RNA (mRNA)IBA 01/2020 - 03/2007
3	Connexin 43 (Connexin43)IBA 01/2019 - 01/2012
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016 - 01/2012
3	PerforinIBA 01/2012 - 10/2009
2	CollagenIBA 11/2023 - 12/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023 - 01/2022
2	trans-sialidaseIBA 05/2023 - 09/2009
2	DNA (Deoxyribonucleic Acid)IBA 04/2023 - 08/2013
2	Therapeutic UsesIBA 01/2022 - 01/2019
2	Type I Tumor Necrosis Factor ReceptorsIBA 09/2017 - 06/2008
2	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 01/2017 - 10/2003
2	Integrin alpha4beta1 (VLA-4)IBA 01/2017 - 10/2003
2	Fibronectins (Fibronectin)IBA 03/2015 - 01/2014
2	AntibodiesIBA 11/2014 - 09/2003
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2012 - 02/2010
2	IsoenzymesIBA 01/2012 - 01/2012
2	InterferonsIBA 10/2011 - 02/2010
2	InterleukinsIBA 02/2010 - 02/2003
2	Membrane Proteins (Integral Membrane Proteins)IBA 10/2009 - 09/2009
2	Cell Adhesion MoleculesIBA 07/2009 - 10/2003
2	Chemokine CCL5IBA 03/2007 - 09/2004
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 07/2004 - 10/2003
1	Amiodarone (Amiodarona)FDA LinkGeneric 05/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2024
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2023
1	Bevacizumab (Avastin)FDA Link 11/2023
1	KininsIBA 04/2023
1	Bradykinin B1 ReceptorIBA 04/2023
1	Colchicine FDA LinkGeneric 11/2022
1	Chloroquine (Aralen)FDA LinkGeneric 11/2022
1	Drug CombinationsIBA 11/2022
1	Sulfadiazine (Sulphadiazine)FDA Link 01/2022
1	methylxanthineIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Protein Kinases (Protein Kinase)IBA 01/2022
1	Pyrimethamine (Daraprim)FDA Link 01/2022
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2022
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2022
1	Chemotactic FactorsIBA 01/2021
1	Sirolimus (Rapamycin)FDA Link 01/2021
1	Interleukin-2 (IL2)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	CCR1 ReceptorsIBA 01/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2020
1	LigandsIBA 01/2019
1	4- (4- (3- (pyridin- 2- yl)- 1H- pyrazol- 4- yl)pyridin- 2- yl)- N- (tetrahydro- 2H- pyran- 4- yl)benzamideIBA 01/2019
1	ChemokinesIBA 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2018
1	NF-kappa B (NF-kB)IBA 12/2017
1	Interleukin-6 (Interleukin 6)IBA 09/2017
1	IntegrinsIBA 01/2017
1	tempolIBA 10/2016
1	Metformin (Glucophage)FDA LinkGeneric 10/2016
1	AntioxidantsIBA 10/2016
1	ResveratrolIBA 10/2016
1	SandIBA 12/2015

Therapy/Procedure

14	Therapeutics 05/2024 - 07/2009
1	Investigational Therapies (Experimental Therapy) 10/2016
1	Combination Drug Therapy (Combination Chemotherapy) 01/2016